Fulltext

Cancer gene and immunotherapy: recent developments

Jantscheff, Peter ; Herrmann, Richard ; Rochlitz, Christoph

In: Medical Oncology, 1999, vol. 16, no. 2, p. 78-85

Ajouter à la liste personnelle
    Titre
    • Cancer gene and immunotherapy: recent developments
    Auteur
    • Jantscheff, Peter. Department of Research/Molecular Cancer Research, Kantosspital Basel, Room 301, Hebelstr. 20, CH-4031, Basel, Switzerland
    • Herrmann, Richard. Division of Medical Oncology, Kantonsspital, Basel, Switzerland
    • Rochlitz, Christoph. Division of Medical Oncology, Kantonsspital, Basel, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Medical Oncology, 1999, vol. 16, no. 2, p. 78-85. Humana Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:310207
    Summary
    Gene and immunotherapeutic approaches to treat human malignant tumors are reviewed. Special attention is given to the different strategies of cancer gene therapy and to recent aspects of cytokine-supported tumor immunotherapy or tumor-specific vaccination. The limitations of these therapy approaches are critically discussed especially with respect to immune escape mechanisms